All contributors to Academy educational and leadership activities must disclose all financial relationships (defined below) to the Academy annually. The ACCME requires the Academy to disclose the following to participants prior to the activity:
- All financial relationships with Commercial Companies that contributors and their immediate family have had within the previous 12 months. A commercial company is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients.
- Meeting presenters, authors, contributors or reviewers who report they have no known financial relationships to disclose.
For purposes of this disclosure, a known financial relationship is defined as any financial gain or expectancy of financial gain brought to the Contributor or the Contributor’s immediate family (defined as spouse, domestic partner, parent, child or spouse of child, or sibling or spouse of sibling of the Contributor) by:
- Direct or indirect compensation;
- Ownership of stock in the producing company;
- Stock options and/or warrants in the producing company, even if they have not been exercised or they are not currently exercisable;
- Financial support or funding to the investigator, including research support from government agencies (e.g., NIH), device manufacturers, and\or pharmaceutical companies; or
- Involvement with any for-profit corporation that is likely to become involved in activities directly impacting the Academy where the Contributor or the Contributor’s family is a director or recipient.
Description of Financial Interests
|Consultant / Advisor
||Consultant fee, paid advisory boards, or fees for attending a meeting.
||Employed by or received a W2 from a commercial company.
||Lecture fees or honoraria, travel fees or reimbursements when speaking at the invitation of a commercial company.
|Equity / Stock Owner
||Equity ownership/stock options in publicly or privately traded firms, excluding mutual funds.
|Patents / Royalty
||Patents and/or royalties for intellectual property.
||Grant support or other financial support to the investigator from all sources, including research support from government agencies (e.g., NIH), foundations, device manufacturers, and\or pharmaceutical companies.
When and How to Disclose
Financial disclosures must involve both the following steps:
- Each presenter must have a first slide pertaining to financial interests. This first slide must either:
Presenters are required to verbally state at the start of the talk any financial interests that specifically pertain to their presentation. If there is nothing to disclose, verbally state that you do not have any financial interests or relationships to disclose.
- Disclose all financial interests, or
- If there is nothing to disclose, the slide must state, “I have no financial interests or relationships to disclose.”
Even with these acknowledgements, the Academy’s Annual Meeting Program Committee expects that all presenters will give a fair and unbiased scientific talk.
A PowerPoint disclosure slide is made available to download for your presentation in Presenter Central.
Financial disclosure is something the Academy takes very seriously. During and after the meeting, Academy staff will be conducting spot checks of presentations to ensure the first-slide policy is followed. Any presenter who does not follow this policy will receive an official warning letter after the meeting and may result in exclusion from future meeting programs.